Florida International University
fiu.eduTotal trials
101
Active
27
Phase 3
2
Total enrollment
18,114
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Methylphenidate Hydrochloride ER | — | — | — | — | — | 1 | |
| Relistor Injectable Product | — | — | — | — | — | 1 |
Next readouts
- 2025-08-08
- 2026-07-30
Top conditions
- ADHD7
- Attention Deficit Hyperactivity Disorder7
- HIV Infections6
- Parenting5
- Anxiety Disorders5
- Electronic Cigarette Use4
- Medication Adherence3
- Behavior Problem3
Frequently asked questions about Florida International University
- How many clinical trials does Florida International University have on ClinicalTrials.gov?
- Florida International University is listed as the lead sponsor on 101 clinical trials in ClinicalTrials.gov, 27 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Florida International University's trials are in Phase 3?
- 2 of Florida International University's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Florida International University focus on?
- Florida International University's most-studied conditions on ClinicalTrials.gov are ADHD, Attention Deficit Hyperactivity Disorder, HIV Infections, Parenting, Anxiety Disorders.
- When are Florida International University's next clinical trial readouts?
- Florida International University has 2 upcoming primary-completion readouts tracked here; the soonest is “Single and Combined Effects of Behavioral, Academic, and Medication Treatments for ADHD in the Classroom”, expected around 2025-08-08.